"The testing and treatments provided by Lilly are critical for accurate diagnosis and development of precision medicine," said Bonnie J. Addario, founder of the ALCF and a stage 3B lung cancer survivor. "Together we are setting the stage for a new, personalized standard of care with the goal of improving outcomes for all lung cancer patients."
While the understanding of the diagnosis and treatment of lung cancer has improved, there is additional work to be done. In 2016, nearly 160,000 Americans will die of the disease.1 The ultimate goal of ALCF is to be the global leader fighting lung cancer and the largest source of nonprofit funding dedicated to turning lung cancer into a manageable, curable disease by the year 2023.
"Lilly is proud to contribute to efforts to support and improve outcomes for people living with lung cancer, to identify new potential treatment options and to reduce the stigma of the disease. Working with the ALCF to empower patients and their family members by connecting them around the world with resources and a support network is part of that urgent mission," said Katherine Sugarman, M.D., vice president and global thoracic platform team leader for Lilly Oncology. "Efforts like this are part of Lilly's deep commitment to understand the journey and make life better for those affected by cancer."
Lilly is responsible for the "Shared Voice" program, which brings together a distinguished panel of lung cancer and communication experts to explore how patient-centered communication improves decision making, patient understanding and patient satisfaction for lung cancer patients. For more information go to http://www.lillyoncology.com/shared-voice.html
The following awards will be given to the below honorees at the Gala:
- The Dr. Fred Marcus Simply the Best Award: Eli Lilly and Company.
- Asclepius Award: Ravi Salgia, M.D., Ph.D, City of Hope professor and chair of the Department of Medical Oncology and Therapeutics Research.
- A Breath Away From the Cure Award: David Ross Camidge, M.D., Ph.D, director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado.
For more information about the "Simply the Best" Dinner and Gala visit:
About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation's goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised nearly $30 million for lung cancer research and related programs. For more information about the ALCF please visit www.lungcancerfoundation.org or follow us on Facebook or Twitter.
About Lilly Oncology
For more than fifty years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly's commitment to people with cancer, please visit www.LillyOncology.com.
1 American Cancer Society. Cancer Facts & Figures 2016. Atlanta: American Cancer Society; 2016
Logo - http://photos.prnewswire.com/prnh/20160225/337506LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/eli-lilly-and-company-is-simply-the-best-for-supporting-lung-cancer-survivors-at-annual-gala-300361049.html
SOURCE Bonnie J. Addario Lung Cancer Foundation